Cargando…
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
A review of the literature finds that women diagnosed with breast cancer, who were on an aspirin regimen, experienced a decreased risk of distant metastases and death. Several recent studies have reported an improvement in overall survival in colorectal cancer patients who harbored mutations in the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788696/ https://www.ncbi.nlm.nih.gov/pubmed/26915040 http://dx.doi.org/10.1007/s10549-016-3729-8 |